24 Lupus Clinical Trials in New York, NY (2026)

Q: How do I join a clinical trial in New York?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you.

Recruiting Lupus Studies in New York

NCT03487185Recruiting

Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy

A randomized controlled trial of 1,500 women to assess whether treatment of obstructive sleep apnea with continuous positive airway pressure (CPAP) in pregnancy will result in a reduction in the rate ...

New York, NYNA1,500 participantsThe George Washington University Biostatistics Center

View Study Details

NCT00198068Recruiting

Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)

The PROMISSE Study is an observational study of 700 pregnant patients, enrolled at nine major clinical centers. The purpose of the study is 1) to determine whether certain proteins (called complement ...

New York, NY700 participantsHospital for Special Surgery, New York

View Study Details

NCT05799378Recruiting

Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

Hydroxychloroquine (HCQ) is a systemic lupus erythematosus (SLE) medication that has been very effective in reducing lupus disease activity and keeping patients stable with reduced symptoms. Despite a...

New York, NYPHASE3330 participantsNYU Langone Health

View Study Details

NCT05559671Recruiting

Safety of the Herpes Zoster Subunit Vaccine in Lupus

This randomized, double-blind, placebo-controlled, non-inferiority crossover study will evaluate the Herpes Zoster Sunbit (HZ/su) vaccine in SLE patients in order to evaluate safety and immunogenicity...

New York, NYPHASE4224 participantsNYU Langone Health

View Study Details

NCT07082829Recruiting

A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age

Characterize the safety, tolerability and pharmacokinetics of ORX142 following single and multiple doses....

New York, NYPHASE1208 participantsCentessa Pharmaceuticals (UK) Limited

View Study Details

NCT05988385Recruiting

The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study

The Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL) study is a 5-year, multicenter randomized open-label trial that will screen 400 cognitively normal older...

New York, NYNA200 participantsCalifornia Pacific Medical Center Research Institute

View Study Details

NCT06897930Recruiting

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

This is a Phase 1b/2, single-arm, open-label, multi-center, clinical study of AZD0120, a CD19/BCMA dual CAR T cell therapy, to evaluate the safety, tolerability, and efficacy in adult participants wit...

New York, NYPHASE1150 participantsAstraZeneca

View Study Details

NCT05289063Recruiting

Vascular Endothelial Dysfunction in Sleep Apnea

This double-blind placebo-controlled parallel group randomized study design will be used to test whether 4 weeks of atorvastatin 10 mg daily reduces levels of inflammatory markers in OSA patients trea...

New York, NYPHASE1110 participantsColumbia University

View Study Details

NCT05538208Recruiting

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

The study is a 1-year 2-part double-blinded placebo controlled 2-arm clinical trial. Treatment arms are (1) MMF dosed as per body-surface area (MMFBSA; 600mg/m2 body surface area per dose about every ...

New York, NYPHASE2105 participantsChildren's Hospital Medical Center, Cincinnati

View Study Details

NCT07477236Recruiting

MyVitalC: Sleep and Everyday Headache Management

Sleep disturbance and recurring headaches can negatively affect daily functioning, mood, and productivity. MyVitalC (ESS60 in extra virgin olive oil) is a commercially available dietary supplement tha...

New York, NYNA100 participantsEfforia, Inc

View Study Details

NCT05835310Recruiting

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

A Study to evaluate the PK, PD, efficacy, and safety of Anifrolumab in children with moderate to severe active SLE...

New York, NYPHASE3100 participantsAstraZeneca

View Study Details

NCT07281963Recruiting

Chilipad Sleep Optimization Study

This study evaluates the Chilipad Dock Pro Bed Cooling System and Sleep Tracker, examining how bed temperature influences sleep quality and overall well-being....

New York, NYNA100 participantsEfforia, Inc

View Study Details

NCT07294482Recruiting

The Effects on Sleep Quality of 1:4 Reishi Liquid Extract

Examining the effects of 1ml of Reishi mushroom extract (1:4 extraction ratio, two hot water extractions and an alcohol extraction), taken daily, 30 mins before bed on perceived sleep quality and stre...

New York, NYNA100 participantsEfforia, Inc

View Study Details

NCT07298161Recruiting

Evaluating SleepWhale Drops for Rest & Resilience

30-day study evaluating SleepWhale Natural Sleep Drops (Extra Strength)-formulated to support deeper sleep and better days....

New York, NYNA100 participantsEfforia, Inc

View Study Details

NCT07085104Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

This is a first-in-human, single-arm, open-label study evaluating the safety, tolerability, and preliminary efficacy of ALLO-329 in adults with autoimmune diseases: systemic lupus erythematosus (SLE) ...

New York, NYPHASE166 participantsAllogene Therapeutics

View Study Details

NCT07107659Recruiting

Safety and Efficacy of ONT01 in Lupus

ONT01 is a drug that is being studied for the treatment of Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE) and is not approved by the FDA. The purpose of this study is to better determine ...

New York, NYEARLY_PHASE161 participantsHospital for Special Surgery, New York

View Study Details

NCT06720545Recruiting

Cardiometabolic Risk Effects of Short-term Cessation of Neurostimulation Therapy

Hypoglossal nerve stimulation (HGNS) is an implantable therapy that treats obstructive sleep apnea. The study will evaluate the effect of this treatment on cardiovascular and metabolism-related measu...

New York, NYNA60 participantsColumbia University

View Study Details

NCT07090395Recruiting

Severe Label Expansion for EVO Products Trial

Title: Severe Label Expansion for EVO Positioner (SLEEP) Study Description: Single-arm study to determine the safety and effectiveness of treating severe obstructive sleep apnea using the EVO Sleep an...

New York, NYNA49 participantsProSomnus Sleep Technologies

View Study Details

NCT06875960Recruiting

A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

The purpose of this study is to allow the continued administration of Deucravacitinib in participants with Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (...

New York, NYPHASE435 participantsBristol-Myers Squibb

View Study Details

NCT07218822Recruiting

Impact of Pistachio Consumption on Sleep

Sleep is essential for life and overall health. Unfortunately, a large portion of the population in the U.S. and worldwide experience sleep deficiencies, which increase their risk for developing chron...

New York, NYNA28 participantsColumbia University

View Study Details

NCT06613360Recruiting

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

Phase 1b, open-label study of CLN-978 administered subcutaneously in patients with Moderate to Severe Systemic Lupus Erythematosus (SLE)....

New York, NYPHASE124 participantsCullinan Therapeutics Inc.

View Study Details

NCT06430086Recruiting

Mechanistic Effect of Walnut Consumption on Sleep Quality

Poor sleep quality is very common in modern society. Walnuts contain many nutrients that may be helpful for sleep, including melatonin and polyphenols. Some studies show that eating foods high in mela...

New York, NYNA24 participantsColumbia University

View Study Details

NCT06698809Recruiting

Obstructive Sleep Apnea Therapeutic Intervention for REsiDual Sleepiness

Obstructive sleep apnea (OSA) is a sleep disorder that is commonly treated using positive airway pressure, yet 50% of patients still experience residual sleepiness after successful therapy. A potentia...

New York, NYNA22 participantsNYU Langone Health

View Study Details

NCT07219563Recruiting

Alnuctamab for Refractory SLE (LATTE Study)

This study will assess the safety and preliminary efficacy of the bi-specific TCE, alnuctamab (known as BMS-986349, CC-93269, EM901), targeting BCMA in patients with moderate to severe SLE, refractory...

New York, NYPHASE121 participantsIcahn School of Medicine at Mount Sinai

View Study Details

About Lupus Clinical Trials in New York

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect the joints, skin, kidneys, brain, and other organs. It is more common in women and often involves periods of flares and remission. Treatment includes antimalarials, immunosuppressants, and biologics.

There are currently 24 lupus clinical trials recruiting participants in New York, NY. These studies are seeking a combined 4,417 participants. Research is being sponsored by The George Washington University Biostatistics Center, Hospital for Special Surgery, New York, NYU Langone Health and 11 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lupus Clinical Trials in New York — FAQ

Are there lupus clinical trials in New York?

Yes, there are 24 lupus clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New York?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.

Are clinical trials in New York free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.

What lupus treatments are being tested?

The 24 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for lupus.

Data updated July 17, 2026 from ClinicalTrials.gov